Novogen Sues Chattem Over Preventative Health Methods

Law360, New York (March 10, 2006, 12:00 AM EST) -- Australian biotechnology company Novogen Research Party Ltd. has whacked Chattem Inc. with a lawsuit, accusing the health manufacturer of infringing on a patented method used to treat various female ailments.

Novogen filed the lawsuit in U.S. District Court for the Southern District of New York on Wednesday, charging the Tennessee corporation with violating its intellectual property designed to minister to breast cancer, pre-menstrual syndrome and menopause.

At the heart of the dispute is the patent entitled “Methods for treating or reducing pre-disposition to breast cancer, pre-menstrual...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.